Starting medication-assisted treatment (MAT) or medications for opioid use disorder (MOUD) can bring up a lot of questions. Will it ease withdrawal? Will cravings go away? Is methadone better than buprenorphine alone or buprenorphine combined with naloxone?
There is no single answer that works for everyone. A medication that gives one person stability may cause side effects, access problems, or new concerns for someone else. Treatment can also change over time as your health, goals, and daily life change.
Members of MyOpioidRecoveryTeam have shared a wide range of experiences with MAT and MOUD. Their stories are not medical advice, but they can help show why people often have questions about medication treatment. Finding the right approach may take time, support, and honest conversations with a healthcare professional.
Medication-assisted treatment traditionally refers to using medication along with counseling, behavioral healthcare, or other recovery support.
Many healthcare professionals now use the term “medications for opioid use disorder.” This wording recognizes that medication is an evidence-based treatment for OUD, not simply an add-on to counseling.
The U.S. Food and Drug Administration (FDA) has approved three treatments used in MOUD:
For some people, medication helps interrupt the cycle of withdrawal, cravings, and constant opioid use. MOUD has been associated with a smaller risk of overdose or overall mortality. It can also create more room to focus on work, housing, relationships, and daily stability.
One member said, “I’m on methadone. It works if you work the program. I’ve come a long way from where I used to be. I still have a ways to go, but I’m getting there. Methadone saved my life.”
Another member described how buprenorphine plus naloxone supported their recovery: “I have been in buprenorphine/naloxone (Suboxone) therapy and owe my life to it. I tried getting sober without any medication and failed more than once. … Since committing myself to getting clean, each day has gotten easier. I started thinking less about cravings and more about rebuilding my life.”

Success with MAT can look different from person to person. It may mean fewer cravings, relief from withdrawal, more stability, or simply having a better chance to stay engaged in treatment.
People comparing methadone and buprenorphine often want one clear winner. But they can be equally effective in helping people reduce opioid use — and methadone may help some people stay in treatment longer.
One member said methadone helped but eventually became difficult to manage: “Tried MAT and had some success while on methadone. However, the methadone became a burden as it came with its own set of problems. I recently detoxed … and now take Suboxone, which is less problematic for me.”
Another member had the opposite experience in transitioning from buprenorphine plus naloxone to methadone: “Have almost zero craving. … It also seems to help with the little aches and pains.”
These experiences show why medication choice is individual. The best fit may depend on symptoms, treatment goals, health history, side effects, and access to care.
Members often describe withdrawal relief and craving relief as two separate parts of treatment. Buprenorphine can reduce cravings and withdrawal symptoms, but that does not mean every person feels the same level of benefit in both areas.

One member shared, “Had to go to Suboxone but it doesn’t help with the cravings anymore like the first few months.”
Another member wrote, “I am presently on Suboxone and have been taking it for nearly 14 years. It takes away the withdrawal symptoms, but doesn’t stop the cravings.”
Cravings can also be affected by stress, triggers, environment, mental health, and how well a treatment plan fits a person’s needs. If cravings get worse or start to feel harder to manage, it’s important to bring that up with a clinician rather than changing treatment on your own.
The choice between buprenorphine alone versus buprenorphine combined with naloxone isn’t always just about preference. It can also involve side effects, insurance coverage, how a medication is started, and what a prescriber thinks is safest.
One member described the effort involved in getting their treatment covered: “When my psychiatrist prescribed it, I had to fight with my insurance company over a preauthorization. It was frustrating, and I started to lose hope.”
The same member also described having severe withdrawal symptoms while attempting to start their medication: “Even after waiting a full 24 to 36 hours after last use, I ended up having precipitated withdrawals anyway. I’ve attempted to take the med twice now and had the same outcome both times, so now a different doctor is trying the dosing differently to see how that will work.”

Because medication starts and switches can be complicated, they should be guided by a prescriber who knows your treatment history.
Some people feel comfortable staying on medication long term. Others start wondering whether they are ready to lower their dose or stop.
Detoxing on your own without medications for opioid use disorder is not recommended. Doing so increases the risks of resuming drug use, overdose, and death from an overdose.
One member described both progress and difficulty while reducing buprenorphine plus naloxone: “I’ve been on Suboxone for about four years. … Trying to wean myself off of it. Down to one pill a day now doing OK, but some days it’s a struggle!! Always sluggish and tired, but I haven’t and will not give up!”
There is no single timeline that works for everyone. A taper is safest when it is planned with a healthcare professional who can weigh cravings, stress, recovery stability, and the risk of return to use.
A medication may help with opioid use or withdrawal and still be hard to keep up with in everyday life. Many doctors, nurse practitioners, and physician assistants can prescribe buprenorphine, while methadone for OUD is generally available only through approved opioid treatment programs. That difference alone can shape cost, travel time, and how realistic treatment feels.

One member explained how chronic pain affected their decision, noting that for them, methadone has been the best pain reliever: “I’m decreasing my dose, but am concerned because I do have chronic pain. If I get off, I will be in pain without help. So, I’m at a crossroad.”
Another member described the stress of losing affordable care: “I really need help finding someone that takes my insurance. … I found a psychiatrist, but I have to pay $45 every time I see her, and I can’t afford to take the drug test where she wants me to go.”
If side effects, pain, cost, or access problems are making treatment harder, it may help to ask an opioid use disorder specialist what other options or supports may be available.
MAT experiences vary widely. What feels freeing to one person may feel restrictive to another. Some people find the right medication quickly, while others need time, support, and careful medical guidance to find an approach that works.
Member stories can help people feel less alone. But treatment decisions are best made with a qualified healthcare professional who understands your medical history, symptoms, and recovery goals.
On MyOpioidRecoveryTeam, people share their experiences with opioid use disorder, get advice, and find support from others who understand.
What has shaped your experience with methadone, buprenorphine, or another form of MAT? Let others know in the comments below.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.